Reaction

Colitis Microscopic reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 4,632 reports · 143 co-occurring drugs

As of the last recalculation, Colitis Microscopic appears in 4,632 FAERS reports alongside 143 co-occurring drug terms. The strongest observed disproportionality signal is DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE (PRR 45.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Dorzolamide Hydrochloride And Timolol Maleate	79	45.7	46.1
Icosapent Ethyl	44	23.4	23.6
Olmesartan Medoxomil	162	20.9	21.0
Cholestyramine	49	18.4	18.5
Budesonide	222	17.7	17.8
Calcium Gluconate	45	16.9	17.0
Rasagiline Mesylate	41	16.7	16.7
Lansoprazole	559	15.9	16.0
Dimenhydrinate	33	14.0	14.0
Desoximetasone	56	13.4	13.4
Loperamide Hydrochloride And Dimethicone	90	12.8	12.9
Sertraline	314	12.8	12.9
Valsartan Oral	148	12.6	12.6
Rabeprazole	60	12.3	12.3
Latanoprost	131	12.0	12.0
Loperamide Hydrochloride	113	11.6	11.6
Potassium Chloride, Dextrose Monohydrate	212	10.7	10.8
Potassium Chloride Oral	212	10.7	10.8
Potassium Chloride Extended-Release	212	10.7	10.7
Estradiol Gel 0.1%	105	10.7	10.7
Estradiol Transdermal	105	10.7	10.7
Hydroxychloroquine Sulfate	206	10.6	10.6
Duloxetine	154	10.2	10.3
Hydroxychloroquine	164	10.2	10.2
Loperamide Hydrochloride Oral	23	10.2	10.2
Certolizumab Pegol	250	10.1	10.1
Tocilizumab	232	9.6	9.6
Vedolizumab	176	9.5	9.5
Sulfasalazine	157	9.3	9.3
Escitslopram	113	8.9	8.9
Potassium Chloride	215	8.8	8.9
Nebivolol	31	8.8	8.8
Loperamide Hcl	25	8.8	8.8
Rosuvastatin Calcium	54	8.7	8.7
Estradiol	160	8.6	8.6
Leflunomide	191	8.5	8.5
Venlafaxine	127	8.2	8.2
Tofacitinib Citrate	23	7.9	7.9
Escitalopram Oxalate	122	7.7	7.7
Abatacept	224	7.6	7.6
Paroxetine Hydrochloride Hemihydrate	55	7.5	7.5
Paroxetine	55	7.3	7.4
Morphine	117	7.2	7.2
Valsartan	161	7.1	7.1
Moxifloxacin Hydrochloride	30	6.7	6.7
Aflibercept	45	6.5	6.5
Diphenoxylate Hydrochloride And Atropine Sulfate	19	6.3	6.3
Isosorbide Mononitrate	28	6.1	6.1
Levodopa	16	6.0	6.0
Pramipexole	20	5.9	5.9
Adalimumab-Fkjp	59	5.8	5.8
Adalimumab-Aaty	58	5.6	5.6
Cefuroxime	14	5.5	5.5
Esomeprazole	75	5.5	5.5
Bisoprolol Fumarate	161	5.5	5.5
Duloxetine Hydrochloride	215	5.3	5.3
Ramipril	143	5.3	5.3
Pitavastatin Calcium	12	5.3	5.3
Venlafaxine Hydrochloride	151	5.3	5.3
Adalimumab-Adaz	61	5.3	5.3
Trimethoprim	13	5.0	5.0
Pravastatin Sodium	21	4.8	4.8
Sertraline Hydrochloride	121	4.7	4.7
Ciclesonide	14	4.6	4.6
Ocrelizumab	63	4.6	4.6
Mesalamine	57	4.6	4.6
Irbesartan	45	4.6	4.6
Teriflunomide	45	4.5	4.5
Escitalopram	137	4.5	4.5
Nevirapine	9	4.5	4.5
Calcium	144	4.5	4.5
Carboxymethylcellulose Sodium	9	4.3	4.3
Pantoprazole	233	4.3	4.3
Ipilimumab	41	4.3	4.3
Abacavir Sulfate	9	4.2	4.2
Nebivolol Hydrochloride	31	4.1	4.2
Pembrolizumab	95	4.1	4.1
Indapamide	16	4.0	4.0
Fluorouracil Cream, 0.5%	67	4.0	4.0
Baclofen	75	4.0	4.0
Nivolumab	84	4.0	4.0
Fluorouracil	67	3.9	3.9
Hyoscyamine Sulfate	8	3.9	3.9
Dapagliflozin	27	3.9	3.9
Pancrelipase	33	3.9	3.9
Levothyroxine Sodium Anhydrous	84	3.8	3.8
Telmisartan	15	3.8	3.8
Trazodone Hydrochloride	13	3.7	3.7
Donepezil Hydrochloride	30	3.7	3.7
Fluoxetine	54	3.7	3.7
Calcium, Magnesium, Potassium, And Sodium Oxybates	7	3.7	3.7
Paroxetine Hydrochloride	73	3.6	3.6
Colchicine	21	3.6	3.6
Torsemide	26	3.5	3.5
Tofacitinib	137	3.4	3.4
Fluoxetine Hydrochloride	95	3.4	3.4
Memantine	10	3.3	3.3
Memantine Hydrochloride	10	3.3	3.3
Nintedanib	22	3.2	3.2
Anastrozole Tablets	15	3.1	3.1
Methotrexate Sodium	320	3.1	3.1
Valacyclovir	28	3.0	3.0
Infliximab	144	3.0	3.0
Isotretinoin	33	3.0	3.0
Cetiirizine	28	3.0	3.0
Amantadine	10	2.9	2.9
Secukinumab	101	2.9	2.9
Amlodipine	167	2.9	2.9
Clopidogrel Bisulfate	64	2.8	2.8
Ixekizumab	23	2.8	2.8
Lovastatin	15	2.6	2.6
Ticagrelor	18	2.5	2.5
Golimumab	48	2.5	2.5
Anakinra	9	2.4	2.4
Rifaximin	11	2.4	2.4
Cladribine	5	2.3	2.3
Desvenlafaxine Succinate	14	2.3	2.3
Etanercept	298	2.3	2.3
Encorafenib	5	2.3	2.3
Alpelisib	4	2.1	2.1
Dexlansoprazole	19	2.1	2.1
Ofatumumab	15	2.0	2.0
Paclitaxel (Aibumin-Bound)	37	2.0	2.0
Pertuzumab	12	2.0	2.0
Bimekizumab	9	1.9	1.9
Vemurafenib	5	1.9	1.9
Atezolizumab	16	1.9	1.9
Ranitidine Hydrochloride	22	1.8	1.8
Prasugrel Hydrochloride	4	1.8	1.8
Paclitaxel	37	1.7	1.7
Durvalumab	7	1.5	1.5
Bosutinib	3	1.5	1.5
Ranitidine	66	1.5	1.5
Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate	6	1.5	1.5
Docetaxel Anhydrous	22	1.5	1.5
Docetaxel	22	1.5	1.5
Cetuximab	10	1.4	1.4
Fremanezumab-Vfrm	3	1.2	1.2
Axitinib	5	1.2	1.2
Alirocumab	6	1.1	1.1
Osimertinib	6	0.8	0.8
Apremilast	27	0.8	0.8
Evolocumab	23	0.6	0.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.